Replies to post #126758 on Biotech Values

[DewDiligence]

If it was fully substitutable, then no need for labeling discussions, right?

If the product were substitutable, there would be no need for labeling discussions of any consequence. Note that branded Lovenox no longer has a Hatch-Waxman “carve-out” for the STEMI indication, as it once did (#msg-43243987).